Common parlance and Ayurvedic text support determine tariff classification; food supplement classification, extended limitation and main penalty upheld.

Products claimed as Ayurvedic medicines are classified under excise tariff by common parlance and by whether their ingredients and claimed use are supported in authoritative Ayurvedic texts; labels, promotional material and drug licences do not by themselves control classification. On that test, Reishi Gano and Ganocelium were treated as food supplements under Heading 2108.99, not Ayurvedic Proprietary Medicines under Heading 3003.39. The change in classification, viewed as a misdeclaration after investigation, justified the extended period and the main penalty under Section 11AC. Confiscation and redemption fine were set aside, the Rule 25 penalty on the main appellant was dropped, and the other penalties were substantially reduced as excessive.

---

---

Issues: (i) Whether Reishi Gano and Ganocelium were classifiable as Ayurvedic Proprietary Medicines under Heading 3003.39 or as food supplements under Heading 2108.99 of the First Schedule to the Central Excise Tariff Act, 1985; (ii) whether the extended period of limitation and penalties were invocable; (iii) whether confiscation and redemption fine could be sustained, and whether the quantum of penalties required modification.

Issue (i): Whether Reishi Gano and Ganocelium were classifiable as Ayurvedic Proprietary Medicines under Heading 3003.39 or as food supplements under Heading 2108.99 of the First Schedule to the Central Excise Tariff Act, 1985.

Analysis: The products were tested on the basis of common parlance and the ingredients-based inquiry. The labels and promotional material showed the goods as products for general health and well-being, not as medicines for any identified disease. The earlier marketing of the goods as food supplements, the distributors' statements, and the nature of the literature supplied with the products supported the conclusion that consumers knew them as food supplements. On the second limb, the materials relied upon did not establish that the relevant ingredients were specifically recognized in authoritative Ayurvedic texts for the claimed medicinal use. The drug licences and allied materials were found insufficient to govern tariff classification under excise law, especially where the factual basis for the licences was disputed.

Conclusion: The goods were correctly classifiable under Heading 2108.99 as food supplements, and not under Heading 3003.39 as Ayurvedic Proprietary Medicines.

Issue (ii): Whether the extended period of limitation and penalties were invocable.

Analysis: The change in classification was held to be unsupported by the record and was treated as a misdeclaration after investigation, with the goods having earlier been imported and sold as food supplements. On that footing, the Tribunal found justification for invoking the extended period. Since the ingredients for penalty were held to be satisfied, the statutory penalty under Section 11AC followed. However, the separate penalties imposed on the other noticees were considered excessive and reduced substantially.

Conclusion: The extended period and the principal penalty under Section 11AC were upheld, while the other penalties were reduced.

Issue (iii): Whether confiscation and redemption fine could be sustained, and whether the quantum of penalties required modification.

Analysis: The confiscation and redemption fine were found excessive because the record did not establish clandestine removal intent in the manner required to sustain such drastic relief. As regards the other penalties, the Tribunal held that they were disproportionate and required interference, while the penalty under Rule 25 on the main appellant was unnecessary in view of the penalty already imposed under Section 11AC.

Conclusion: Confiscation and redemption fine were set aside, the Rule 25 penalty on the main appellant was set aside, and the other penalties were reduced.

Final Conclusion: The principal excise classification dispute was decided against the assessees, but the punitive consequences were partly diluted by setting aside confiscation and some penalties and by reducing the remaining penalties.

Ratio Decidendi: For tariff classification of a product claimed as an Ayurvedic medicine, the decisive tests are consumer perception in common parlance and whether the claimed ingredients and use are supported by authoritative Ayurvedic texts; drug licences or labels alone do not control excise classification.

---